155 related articles for article (PubMed ID: 202421)
1. Effect of clofibrate on the composition of very low and low density lipoprotein subfractions in type III hyperlipoproteinaemia.
Ballantyne D; Ballantyne FC; Stromberg P; Third JL; Bedford DK
Clin Chim Acta; 1978 Feb; 83(1-2):117-22. PubMed ID: 202421
[TBL] [Abstract][Full Text] [Related]
2. The composition of low (LDL) and very low (VLDL) density lipoprotein subfractions in type III hyperlipoproteinaemia: comparison with normal subjects.
Stromber P; Ballantyne D; Ballantyne FC; Third JL; Bedford DK
Clin Chim Acta; 1977 Aug; 79(1):163-72. PubMed ID: 196790
[TBL] [Abstract][Full Text] [Related]
3. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
Weisweiler P; Schwandt P
Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601
[TBL] [Abstract][Full Text] [Related]
4. Electrophoretic mobility in agarose of very low density lipoprotein subfractions in type III hyperlipoproteinaemia.
Ballantyne FC; Bedford DK; Ballantyne D; Third JL; Stromberg P; Packard CJ
Clin Chim Acta; 1977 Mar; 75(3):487-90. PubMed ID: 192494
[TBL] [Abstract][Full Text] [Related]
5. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
Falko JM; Witztum JL; Schonfeld G; Weidman SW; Kolar JB
Am J Med; 1979 Feb; 66(2):303-10. PubMed ID: 218451
[No Abstract] [Full Text] [Related]
6. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
Gustafson A
Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983
[No Abstract] [Full Text] [Related]
7. Lipoprotein composition and lipoprotein interrelations in 50-year-old men with hyperlipoproteinaemia.
Vessby B; Hedstrand H; Olsson U
Ups J Med Sci; 1976; 81(2):71-8. PubMed ID: 183321
[TBL] [Abstract][Full Text] [Related]
8. One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.
Olsson AG; Lang PD
Atherosclerosis; 1978 Dec; 31(4):429-33. PubMed ID: 215175
[TBL] [Abstract][Full Text] [Related]
9. On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias.
Carlson LA; Olsson G; Ballantyne D
Atherosclerosis; 1977 Apr; 26(4):603-9. PubMed ID: 193526
[TBL] [Abstract][Full Text] [Related]
10. Comparison of behaviour of very low density lipoproteins of type III hyperlipoproteinaemia on electrophoresis on paper and on agarose gel with a note on a late (slow) pre-beta VLDL liproprotein.
Carlson K; Carlson LA
Scand J Clin Lab Invest; 1975 Nov; 35(7):655-60. PubMed ID: 174185
[TBL] [Abstract][Full Text] [Related]
11. The concentration of high density lipoprotein in patients with type IV hyperlipoproteinemia and the effect of clofibrate.
Brook JG; Lavy A; Aviram M; Zinder O
Atherosclerosis; 1980 Aug; 36(4):461-9. PubMed ID: 7417365
[TBL] [Abstract][Full Text] [Related]
12. Clofibrate-induced low density liporotein elevation. Therapeutic implications and treatment by colestipol resin.
Rose HG; Haft GK; Juliano J
Atherosclerosis; 1976; 23(3):413-27. PubMed ID: 178325
[TBL] [Abstract][Full Text] [Related]
13. Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinanemia.
Olsson AG; Lang PD
Atherosclerosis; 1978 Dec; 31(4):421-8. PubMed ID: 215174
[TBL] [Abstract][Full Text] [Related]
14. Gemfibrozil treatment: a comparison with clofibrate.
Howard AN; Ghosh P
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609
[TBL] [Abstract][Full Text] [Related]
15. Very low density and low density lipoprotein subfractions in type III and type IV hyperlipoproteinemia. Chemical and physical properties.
Packard CJ; Shepherd J; Joerns S; Gotto AM; Taunton OD
Biochim Biophys Acta; 1979 Feb; 572(2):269-82. PubMed ID: 218633
[TBL] [Abstract][Full Text] [Related]
16. Change of lipoprotein pattern by clofibrate in hyperglyceridaemia and mixed hyperlipidaemia.
Miettinen TA; Penttilä IM; Lampainen E
Acta Med Scand; 1972 Sep; 192(3):177-82. PubMed ID: 4341290
[No Abstract] [Full Text] [Related]
17. Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
Vessby B; Lithell H; Gustafsson IB; Borberg J
Atherosclerosis; 1979 Aug; 33(4):457-77. PubMed ID: 228684
[TBL] [Abstract][Full Text] [Related]
18. The spectrum of electrophoretic mobility of very low density lipoproteins: role of slower migrating species in endogenous hypertriglyceridemia (type IV hyperlipoproteinemia) and broad-beta disease (type III).
Hazzard ER; Bierman EL
J Lab Clin Med; 1975 Aug; 86(2):239-52. PubMed ID: 168277
[TBL] [Abstract][Full Text] [Related]
19. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
Kesäniemi YA; Grundy SM
JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883
[TBL] [Abstract][Full Text] [Related]
20. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
Weisweiler P; Schwandt P
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():398-401. PubMed ID: 206058
[No Abstract] [Full Text] [Related]
[Next] [New Search]
